Insiders · Profile

Climaco John M

Chief Executive Officer at CNS Pharmaceuticals. Filing since 12 Apr 2023. CIK 0001546797

Company
Date
Role
Action
Shares
Amount
Of holding
1 Feb 2024
Chief Executive Officer
Bought
166,666
$50.00K
340%
16 Aug 2023
Chief Executive Officer
Bought
2,750
$4.94K
5.9%
12 Apr 2023
Chief Executive Officer
Bought
15,000
$10.41K
50.0%
3 decisions on file.